BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3545672)

  • 1. Biosynthesis and processing of class II histocompatibility antigens.
    Cresswell P; Blum JS; Kelner DN; Marks MS
    Crit Rev Immunol; 1987; 7(1):31-53. PubMed ID: 3545672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early events in the assembly of major histocompatibility complex class II heterotrimers from their free subunits.
    Nijenhuis M; Neefjes J
    Eur J Immunol; 1994 Jan; 24(1):247-56. PubMed ID: 8020564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologically discrete conformation isomers of I-A locus-equivalent class II molecules detected in Lewis rats.
    Reske K; Weitzel R
    Eur J Immunol; 1985 Dec; 15(12):1229-39. PubMed ID: 3878790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the Ia-invariant chain complex in the posttranslational processing and transport of Ia and invariant chain glycoproteins.
    Simonis S; Miller J; Cullen SE
    J Immunol; 1989 Dec; 143(11):3619-25. PubMed ID: 2584710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the biosynthesis of cartilage proteoglycan in a model system of cultured chondrocytes from the Swarm rat chondrosarcoma.
    Kimura JH; Lohmander LS; Hascall VC
    J Cell Biochem; 1984; 26(4):261-78. PubMed ID: 6530407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
    Holt GD; Swiedler SJ; Freed JH; Hart GW
    J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C; Schwenk F; Koch N; Möller P
    Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
    Spiro RC; Sairenji T; Humphreys RE
    J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthetic intermediates of HLA class II antigens from B lymphoblastoid cell lines.
    Kelner DN; Cresswell P
    J Immunol; 1986 Oct; 137(8):2632-9. PubMed ID: 3489770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
    Shackelford DA; Strominger JL
    J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
    Machamer CE; Cresswell P
    J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
    Nguyen QV; Reyes VE; Humphreys RE
    Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant chain retains MHC class II molecules in the endocytic pathway.
    Loss GE; Sant AJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3187-97. PubMed ID: 8468464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
    Anderson HA; Roche PA
    J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
    Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
    J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules.
    Germain RN; Rinker AG
    Nature; 1993 Jun; 363(6431):725-8. PubMed ID: 8515815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.